Home›Stock Screener›Krsnaa Diagnostics›Financial Statements

Krsnaa Diagnostics Complete Financial Statements

8 Years of Data
2026 - 2016

In FY2026, Krsnaa Diagnostics (KRSNAA) reported revenue ₹224 Cr, net profit ₹42 Cr and EPS ₹12.86, with a net profit margin of 18.8% and ROE of 4.8%. Full financial statements from FY2016 to FY2026 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore KRSNAA Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 18.75% 2026 data
EBITDA Margin 38.39% 2026 data
Operating Margin 28.00% 2026 data
Return on Assets 3.28% 2026 data
Return on Equity 4.76% 2026 data

Balance Sheet Ratios

Current Ratio 4.46 2026 data
Equity Ratio 68.88% 2026 data
Asset Turnover 0.17 2026 data

KRSNAA Revenue, Net Profit & EBITDA — Year-on-Year Growth

KRSNAA YoY (Mar 2025 vs Mar 2026) — revenue +17.3%, net profit +100.0%, EBITDA +50.9%, expenses +3.8%. Review KRSNAA P/E comparison to evaluate earnings-based valuation against sector peers.

Revenue Growth
+17.3%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
+50.9%
Year-over-Year
Expense Growth
+3.8%
Year-over-Year
Assets Growth
+9.4%
Year-over-Year
Equity Growth
+9.0%
Year-over-Year
Operating Cash Flow Growth
-68.4%
Year-over-Year
Investing Cash Flow Growth
-18.3%
Year-over-Year
Financing Cash Flow Growth
+354.5%
Year-over-Year

KRSNAA Income Statement — Revenue, EBITDA & Net Profit

Krsnaa Diagnostics revenue ₹224 Cr, EBITDA ₹86 Cr, net profit ₹42 Cr, EPS ₹12.86 (2026) — net profit margin 18.8%. For live price, earnings ratios and company overview, see KRSNAA share price screener.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Jun 2021 Dec 2021
Revenue 224 210 191 197 185 191 171 178 184 160 139 144 162 127 112 118 123 112 136 111
Expenses 138 147 133 142 135 137 123 128 129 124 99 108 121 92 80 85 89 76 91 77
EBITDA 86 63 57 55 50 54 48 50 54 36 40 36 42 35 32 32 34 35 45 34
Operating Profit Margin % 28.00% 29.00% 28.00% 27.00% 26.00% 27.00% 26.00% 25.00% 26.00% 20.00% 26.00% 22.00% 24.00% 25.00% 26.00% 25.00% 25.00% 29.00% 31.00% 28.00%
Depreciation 23 24 22 22 23 22 18 22 23 20 15 16 21 13 10 12 14 10 10 11
Interest 12 8 7 6 8 6 7 5 6 3 2 2 4 2 2 1 2 8 6 2
Profit Before Tax 52 32 29 27 20 25 23 23 26 13 24 18 16 20 20 19 18 17 29 21
Tax 10 8 8 7 4 6 4 5 6 3 5 3 3 5 2 5 4 4 7 5
Net Profit 42 24 21 21 15 20 19 18 19 11 19 15 13 15 18 14 14 13 22 16
Earnings Per Share (₹) 12.86 7.38 6.40 6.35 4.72 6.07 5.80 5.55 6.01 3.35 6.03 4.66 4.09 5.73 5.40 4.53 4.35 4.51 16.62 5.67

KRSNAA Balance Sheet — Assets, Liabilities & Shareholders' Equity

KRSNAA total assets ₹1,282 Cr, total equity ₹883 Cr, total liabilities ₹ Cr (2025) — ROE 4.8%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022
ASSETS
Total Assets 1,282 1,172 910 876
Current Assets 415 421 223 334
Fixed Assets 670 647 471 386
Capital Work in Progress 3 10 26 28
Investments 32 0 0 0
Other Assets 577 515 413 462
LIABILITIES
Total Liabilities
Current Liabilities 93 81 72 71
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 883 810 739 684
Share Capital 16 16 16 16
Reserves & Surplus 867 794 723 669

KRSNAA Cash Flow Statement — Operating, Investing & Financing

Krsnaa Diagnostics operating cash flow ₹24 Cr, investing ₹-129 Cr, financing ₹84 Cr, net cash flow ₹-20 Cr (2024).

Periods ₹ Crores
Particulars March 2024 March 2023 March 2022 March 2017 March 2016
Operating Activities 24 76 128 64 -23
Investing Activities -129 -109 -241 -54 -47
Financing Activities 84 -33 176 -41 105
Net Cash Flow -20 -66 64 -31 36